Rossby Financial’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$275K Buy
1,181
+123
+12% +$28.4K 0.04% 398
2026
Q2
$224K Buy
1,058
+313
+42% +$61.4K 0.04% 363
2026
Q1
$147K Buy
745
+714
+2,303% +$139K 0.03% 448
2025
Q4
$5.38K Sell
31
-85
-73% -$15.5K ﹤0.01% 1092
2025
Q3
$21.1K Hold
116
– – 0.01% 709
2025
Q2
$20.8K Hold
116
– – 0.01% 645
2025
Q1
$20.2K Buy
+116
New +$19.1K 0.01% 621

Other funds holding DGX

Rossby Financial's DGX Position: Q3 2026 in Review

Rossby Financial increased its Quest Diagnostics (DGX) stake by 12% in Q3 2026, buying an estimated $28.4K and bringing the position to 1,181 shares worth $275K. The position accounts for 0.04% of the portfolio, ranked #398.

Rossby Financial first reported a position in DGX in Q1 2025 and has held it in 7 quarters since. 1,139 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Rossby Financial held 1,181 shares of Quest Diagnostics worth $275K as of Q3 2026.
  • Rossby Financial bought 123 Quest Diagnostics shares in Q3 2026, an estimated $28.4K.
  • Quest Diagnostics made up 0.04% of Rossby Financial's portfolio in Q3 2026, its #398 holding.
  • Rossby Financial first reported a position in Quest Diagnostics in Q1 2025 and has held it in 7 quarters since.
  • 1,139 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.